Skip to main content
. 2015 Feb;20(2):127–132.

Figure 1.

Figure 1

The comparison of (a) alanine aminotransferase; (b) aspartate aminotransferase; and (c) total bilirubin in human immunodeficiency virus (HIV)/hepatitis B virus (HBV)/hepatitis C virus (HCV) co-infected group, HIV/HBV co-infected group, HIV/HCV co-infected group and HIV mono-infected group before and after highly active antiretroviral therapy (HAART). *P < 0.01, **P < 0.05, after HAART versus pre-HAART